Found: 105
Select item for more details and to access through your institution.
First-Cycle CSF Use in Breast Cancer and NHL: Guidelines and Recommendations.
- Published in:
- Oncology (08909091), 2006, v. 20, p. 7
- By:
- Publication type:
- Article
Leukemic Polyradiculopathy Due to Blastic Plasmacytoid Dendritic Cell Neoplasm.
- Published in:
- JAMA Dermatology, 2015, v. 151, n. 8, p. 938, doi. 10.1001/jamaneurol.2015.0830
- By:
- Publication type:
- Article
Calr type 1/like mutation in myelofibrosis is the most prominent predictor of momelotinib drug survival and longevity without transplant.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01028-4
- By:
- Publication type:
- Article
One thousand patients with essential thrombocythemia: the Mayo Clinic experience.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-023-00972-x
- By:
- Publication type:
- Article
U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00922-7
- By:
- Publication type:
- Article
Real-world experience with ponatinib therapy in chronic phase chronic myeloid leukemia: impact of depth of response on survival and prior exposure to nilotinib on arterial occlusive events.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00891-x
- By:
- Publication type:
- Article
A systematic review and network meta-analysis comparing azacitidine and decitabine for the treatment of myelodysplastic syndrome.
- Published in:
- Systematic Reviews, 2018, v. 7, n. 1, p. N.PAG, doi. 10.1186/s13643-018-0805-7
- By:
- Publication type:
- Article
The Role of Monoclonal Antibodies in the Management of Leukemia.
- Published in:
- Pharmaceuticals (14248247), 2010, v. 3, n. 10, p. 3258, doi. 10.3390/ph3103258
- By:
- Publication type:
- Article
Prior hypomethylating agent use lacks impact on clinical outcome in patients with secondary acute myeloid leukemia arising from myelodysplastic syndromes treated with standard induction chemotherapy.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Classification of Monocytes, Promonocytes and Monoblasts Using Deep Neural Network Models: An Area of Unmet Need in Diagnostic Hematopathology.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 11, p. 2264, doi. 10.3390/jcm10112264
- By:
- Publication type:
- Article
Clinicopathologic correlates and prognostic impact of lymphoid aggregates in patients with myelodysplastic syndromes.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 4, p. 1627, doi. 10.1111/bjh.19677
- By:
- Publication type:
- Article
Cardiac events in newly diagnosed acute myeloid leukaemia during treatment with venetoclax + hypomethylating agents.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 4, p. 1232, doi. 10.1111/bjh.19325
- By:
- Publication type:
- Article
TP53 variant allele frequency and therapy‐related setting independently predict survival in myelodysplastic syndromes with del(5q).
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 4, p. 1243, doi. 10.1111/bjh.19247
- By:
- Publication type:
- Article
Venetoclax plus hypomethylating agents in DDX41‐mutated acute myeloid leukaemia and myelodysplastic syndrome: Mayo Clinic series on 12 patients.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 1, p. 171, doi. 10.1111/bjh.19105
- By:
- Publication type:
- Article
The clinical and molecular spectrum of ETV6 mutated myeloid neoplasms.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. 279, doi. 10.1111/bjh.18850
- By:
- Publication type:
- Article
Limited activity of fedratinib in myelofibrosis patients relapsed/refractory to ruxolitinib 20 mg twice daily or higher: A real‐world experience.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 4, p. e54, doi. 10.1111/bjh.18284
- By:
- Publication type:
- Article
Cladribine therapy for advanced and indolent systemic mastocytosis: Mayo Clinic experience in 42 consecutive cases.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 975, doi. 10.1111/bjh.17932
- By:
- Publication type:
- Article
De novo isolated myeloid sarcoma: comparative analysis of survival in 19 consecutive cases.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. 413, doi. 10.1111/bjh.17742
- By:
- Publication type:
- Article
Pregnancy in patients with myelofibrosis: Mayo–Florence series of 24 pregnancies in 16 women.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 1, p. 133, doi. 10.1111/bjh.17626
- By:
- Publication type:
- Article
Characteristics of patients with myelodysplastic syndrome with balanced translocations.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 2, p. 244, doi. 10.1111/bjh.16551
- By:
- Publication type:
- Article
Response to erythropoiesis‐stimulating agents in patients with WHO‐defined myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN‐RS‐T).
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 3, p. e104, doi. 10.1111/bjh.16515
- By:
- Publication type:
- Article
Concomitant Erdheim‐Chester disease and chronic myelomonocytic leukaemia: genomic insights into a common clonal origin.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 2, p. e51, doi. 10.1111/bjh.16177
- By:
- Publication type:
- Article
The 2016 revised World Health Organization definition of 'myelodysplastic syndrome with isolated del(5q)'; prognostic implications of single versus double cytogenetic abnormalities.
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 1, p. 57, doi. 10.1111/bjh.14636
- By:
- Publication type:
- Article
Momelotinib treatment-emergent neuropathy: prevalence, risk factors and outcome in 100 patients with myelofibrosis.
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 1, p. 77, doi. 10.1111/bjh.13262
- By:
- Publication type:
- Article
Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. E63, doi. 10.1002/ajh.27180
- By:
- Publication type:
- Article
Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. 193, doi. 10.1002/ajh.27138
- By:
- Publication type:
- Article
Granularity in disease classification impacts survival prediction in advanced systemic mastocytosis: A single institution study of 329 informative cases.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 1, p. 21, doi. 10.1002/ajh.27113
- By:
- Publication type:
- Article
Mast cell cytomorphology and treatment outcome in mast cell leukemia.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 1, p. E5, doi. 10.1002/ajh.27105
- By:
- Publication type:
- Article
Reappraisal of mast cell leukemia based on a single institution review of 16 cases: Mast cell morphology determines clinical outcome.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 1, p. E1, doi. 10.1002/ajh.27089
- By:
- Publication type:
- Article
Sodium‐glucose co‐transporter‐2 inhibitor use and JAK2 unmutated erythrocytosis in 100 consecutive cases.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 7, p. E165, doi. 10.1002/ajh.26933
- By:
- Publication type:
- Article
Spectrum of renal pathological findings in patients with chronic myelomonocytic leukemia and kidney injury.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 6, p. E148, doi. 10.1002/ajh.26902
- By:
- Publication type:
- Article
TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo‐Moffitt study of 156 informative cases.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 4, p. E76, doi. 10.1002/ajh.26845
- By:
- Publication type:
- Article
A phase II study of combination d aunorubicin, cytarabine (A ra‐c), and nilotinib (TA signa) (DATA) in patients newly diagnosed with acute myeloid leukemia with KIT expression.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 472, doi. 10.1002/ajh.26831
- By:
- Publication type:
- Article
Predictors of anemia response to momelotinib therapy in myelofibrosis and impact on survival.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. 282, doi. 10.1002/ajh.26778
- By:
- Publication type:
- Article
Limited activity of luspatercept in myelofibrosis and myeloid neoplasms other than myelodysplastic syndromes with ring sideroblasts.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 12, p. E474, doi. 10.1002/ajh.26749
- By:
- Publication type:
- Article
Momelotinib for myelofibrosis: 12‐year survival data and retrospective comparison to ruxolitinib.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 12, p. E433, doi. 10.1002/ajh.26714
- By:
- Publication type:
- Article
Lenalidomide therapy for primary myelodysplastic syndromes with isolated del(5q): Determinants of response and survival in a real‐world setting.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 10, p. E377, doi. 10.1002/ajh.26672
- By:
- Publication type:
- Article
A dynamic 3‐factor survival model for acute myeloid leukemia that accounts for response to induction chemotherapy.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 9, p. 1127, doi. 10.1002/ajh.26630
- By:
- Publication type:
- Article
Outcomes following venetoclax‐based treatment in therapy‐related myeloid neoplasms.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 8, p. 1013, doi. 10.1002/ajh.26589
- By:
- Publication type:
- Article
Real‐world experience with venetoclax and hypomethylating agents in myelodysplastic syndromes with excess blasts.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 6, p. E214, doi. 10.1002/ajh.26539
- By:
- Publication type:
- Article
Real‐world experience with luspatercept and predictors of response in myelodysplastic syndromes with ring sideroblasts.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 6, p. E210, doi. 10.1002/ajh.26533
- By:
- Publication type:
- Article
Midostaurin therapy for advanced systemic mastocytosis: Mayo Clinic experience in 33 consecutive cases.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 5, p. 630, doi. 10.1002/ajh.26498
- By:
- Publication type:
- Article
Lymphocytopenia predicts shortened survival in myelodysplastic syndrome with ring sideroblasts (MDS‐RS) but not in MDS/MPN‐RS‐T.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. E109, doi. 10.1002/ajh.26448
- By:
- Publication type:
- Article
Gilteritinib clinical activity in relapsed/refractory FLT3 mutated acute myeloid leukemia previously treated with FLT3 inhibitors.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 322, doi. 10.1002/ajh.26447
- By:
- Publication type:
- Article
Venetoclax and hypomethylating agents in older/unfit patients with blastic plasmacytoid dendritic cell neoplasm.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 2, p. E62, doi. 10.1002/ajh.26417
- By:
- Publication type:
- Article
Spectrum of hematological malignancies, clonal evolution and outcomes in 144 Mayo Clinic patients with germline predisposition syndromes.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 11, p. 1450, doi. 10.1002/ajh.26321
- By:
- Publication type:
- Article
Outcomes of venetoclax‐based therapy in chronic phase and blast transformed chronic myelomonocytic leukemia.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 11, p. E433, doi. 10.1002/ajh.26334
- By:
- Publication type:
- Article
Venetoclax with azacitidine or decitabine in blast‐phase myeloproliferative neoplasm: A multicenter series of 32 consecutive cases.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 7, p. 781, doi. 10.1002/ajh.26186
- By:
- Publication type:
- Article
Acute myeloid leukemia after age 70 years: A retrospective comparison of survival following treatment with intensive versus HMA ± venetoclax chemotherapy.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 4, p. E108, doi. 10.1002/ajh.26112
- By:
- Publication type:
- Article
Co-mutational pattern of somatic GATA2-mutated myeloid neoplasms.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 1, p. 211, doi. 10.1007/s00277-022-05016-1
- By:
- Publication type:
- Article